Xlife Sciences AG, the Swiss firm that bridges the gap between life sciences research and healthcare markets, has pulled in $5.4M in new funding.
The company's core mission involves supporting researchers and entrepreneurs in positioning, structuring, and developing groundbreaking concepts. It partners with industrial leaders and universities to take innovative projects beyond the invention stage, frequently out-licensing or selling ventures to bring new technologies to market.


















